- Home
- RPTX vs CLPR Comparison
RPTX vs CLPR Comparison
Compare RPTX & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- CLPR
- Stock Information
- Founded
- RPTX 2016
- CLPR 2015
- Country
- RPTX Canada
- CLPR United States
- Employees
- RPTX N/A
- CLPR N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- RPTX Health Care
- CLPR Real Estate
- Exchange
- RPTX Nasdaq
- CLPR Nasdaq
- Market Cap
- RPTX 64.8M
- CLPR 57.5M
- IPO Year
- RPTX 2020
- CLPR 2017
- Fundamental
- Price
- RPTX $1.57
- CLPR $3.82
- Analyst Decision
- RPTX Strong Buy
- CLPR
- Analyst Count
- RPTX 3
- CLPR 0
- Target Price
- RPTX $4.50
- CLPR N/A
- AVG Volume (30 Days)
- RPTX 112.2K
- CLPR 92.1K
- Earning Date
- RPTX 08-08-2025
- CLPR 08-07-2025
- Dividend Yield
- RPTX N/A
- CLPR 9.95%
- EPS Growth
- RPTX N/A
- CLPR N/A
- EPS
- RPTX N/A
- CLPR N/A
- Revenue
- RPTX $250,000.00
- CLPR $154,103,000.00
- Revenue This Year
- RPTX N/A
- CLPR N/A
- Revenue Next Year
- RPTX N/A
- CLPR N/A
- P/E Ratio
- RPTX N/A
- CLPR N/A
- Revenue Growth
- RPTX N/A
- CLPR 7.69
- 52 Week Low
- RPTX $0.89
- CLPR $3.39
- 52 Week High
- RPTX $4.07
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- RPTX 57.39
- CLPR 50.53
- Support Level
- RPTX $1.54
- CLPR $3.50
- Resistance Level
- RPTX $1.60
- CLPR $4.18
- Average True Range (ATR)
- RPTX 0.05
- CLPR 0.18
- MACD
- RPTX 0.00
- CLPR 0.04
- Stochastic Oscillator
- RPTX 75.00
- CLPR 54.43
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.